To tell if Aricept (donepezil) is helping, track the same two or three daily tasks for steadier function or slower decline. Do not expect restored memory; judge memory, thinking, daily activities, and behavior, then share those notes at each medical review.
Aricept is a once-daily cholinesterase inhibitor for dementia of the Alzheimer's type. The U.S. FDA prescribing information via DailyMed describes efficacy in mild, moderate, and severe disease and states it is not a cure FDA prescribing information via DailyMed.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What counts as helping
- Why the caregiver report matters
- What to track each week
- Timing, dose patience, and when to stop
What counts as helping
Help often means holding steady. The Krka UK summary via the UK regulator emc calls donepezil symptomatic treatment Krka UK summary via the UK regulator emc. So caregivers should look for stabilization or slower decline in memory, thinking, daily tasks, and behavior. A steady result may be needing the same amount of prompting to dress, eat, or take medicines.
A slower decline may be losing a familiar step more slowly than before treatment. Small steadiness in one routine can matter more than test scores. Do not count normal day-to-day variation as failure. Compare the same task under the same conditions across weeks, not single good or bad days.
Why the caregiver report matters
In trials, overall effect was measured with CIBIC-plus. The FDA label via NDC List states that this clinician interview required caregiver information on general, cognitive, behavioral, and daily-living function FDA label via NDC List. Trials also measured cognition with ADAS-cog.
The same FDA label describes it as a validated multi-item scale sampling cognitive domains affected by Alzheimer's disease. UK labeling ties this method to home care. The Krka UK summary via emc states treatment should start only if a caregiver can regularly monitor intake, with benefit reassessed regularly.
What to track each week
Choose tasks you already see daily. Keep the wording fixed so change is visible, such as completing dressing, following a mealtime routine, or joining an evening activity with usual prompts.
Use the same brief check each week: The FDA prescribing information via DailyMed lists those digestive, sleep, energy, muscle, heart-rate, fainting, and bleeding signs as effects to watch. Bring two or three weeks of notes to the visit. A short written record beats memory when decline is slow.
- task attempted, level of help needed, and time taken
- confusion, agitation, withdrawal, or sleep change
- missed doses, vomiting or diarrhea, appetite or weight change, fatigue, cramps, slow pulse, fainting, or signs of stomach bleeding
Timing, dose patience, and when to stop
Give donepezil once daily in the evening before bedtime, at the same time each day. MedlinePlus advises caregivers to supervise adherence in this way MedlinePlus drug guide. Allow the starting dose time to work.
The Krka UK summary via emc directs keeping the 5-mg dose for at least one month so steady levels and earliest response can be assessed before any increase to 10 mg. Tell the prescriber about missed doses or trouble swallowing tablets whole, especially the 23-mg tablet. The same UK summary states benefit should be reassessed regularly and stopped when therapeutic effect is gone, so bring the missed-dose log and swallowing notes to the next visit.
